PARP1
染色质
癌症研究
DNA损伤
基因组不稳定性
泛素
DNA修复
DNA
背景(考古学)
细胞生物学
生物
遗传学
基因
聚ADP核糖聚合酶
聚合酶
古生物学
作者
Guozhen Cao,Liying Ma,Xiaolin Wang,Gongfeng Li,Xinhuang Yao,Jiahui Zhang,Hou Peng,Dongdong Luo,Jinghan Hua,Jiarong Wang,Li Xiang,Yong Peng,Wenchu Lin
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-09-12
标识
DOI:10.1158/0008-5472.can-24-4245
摘要
Abstract Multiple lines of evidence have highlighted the transcriptional regulatory activity of H3.3 at promoters and telomeres. However, H3.3 may also play transcriptional regulation-independent roles. In this study, we demonstrated that overexpression of H3F3A, the gene encoding H3.3, supported the pathogenesis of small cell lung cancer (SCLC) by protecting PARP1 from degradation. Chromatin-associated H3.3 and PARP1 physically interacted, which required the 645-662 amino acid domain of PARP1 and the 20-60 amino acid region of H3.3. Notably, the H3.3-PARP1 interaction blocked K48-linked polyubiquitination of PARP1 at K654 and H3.3 at K36, establishing a positive feedback loop that prevented ubiquitin-mediated degradation of both proteins. Functionally, the oncogenic potential of H3.3 and its role in maintaining genomic stability in SCLC could be partially attributed to the H3.3-PARP1 interaction and the subsequent accumulation of PARP1, which preserved DNA damage repair capacity. Overall, these findings uncover a reciprocal stabilization mechanism between PARP1 and H3.3 within the chromatin context that drives SCLC progression, providing valuable insights into the pathophysiological mechanisms driving this malignancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI